About Presenilin-1
Presenilin-1 (PSEN1) is a protein
from Homo sapiens identified by UniProt accession
P49768, 467 residues long.
MolForge cross-references it against 0 known binders and
504 disease associations.
Target properties
| Protein name | Presenilin-1 |
| UniProt accession | P49768 |
| Gene | PSEN1 |
| Organism | Homo sapiens |
| Length | 467 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Approved drugs hitting this target (1)
DrugCentral-linked approved drugs that act on this protein.
Disease associations (504)
Diseases linked to this target (Open Targets).
- Alzheimer disease 3 · score 0.84
- acne inversa, familial, 3 · score 0.72
- Pick disease · score 0.72
- semantic dementia · score 0.67
- dilated cardiomyopathy 1U · score 0.63
- Alzheimer disease · score 0.58
- early-onset autosomal dominant Alzheimer disease · score 0.56
- frontotemporal dementia · score 0.56
- dilated cardiomyopathy · score 0.51
- dementia · score 0.44
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P49768-F1 | alphafold | PREDICTED | 72.14 | — |
Amino-acid sequence (467 residues)
MTELPAPLSY FQNAQMSEDN HLSNTVRSQN DNRERQEHND RRSLGHPEPL SNGRPQGNSR QVVEQDEEED EELTLKYGAK HVIMLFVPVT LCMVVVVATI KSVSFYTRKD GQLIYTPFTE DTETVGQRAL HSILNAAIMI SVIVVMTILL VVLYKYRCYK VIHAWLIISS LLLLFFFSFI YLGEVFKTYN VAVDYITVAL LIWNFGVVGM ISIHWKGPLR LQQAYLIMIS ALMALVFIKY LPEWTAWLIL AVISVYDLVA VLCPKGPLRM LVETAQERNE TLFPALIYSS TMVWLVNMAE GDPEAQRRVS KNSKYNAEST ERESQDTVAE NDDGGFSEEW EAQRDSHLGP HRSTPESRAA VQELSSSILA GEDPEERGVK LGLGDFIFYS VLVGKASATA SGDWNTTIAC FVAILIGLCL TLLLLAIFKK ALPALPISIT FGLVFYFATD YLVQPFMDQL AFHQFYI
Explore Presenilin-1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets